Genotype-specific Redox Chemotherapy Targeting NQO1*2 Breast Cancer

被引：0
|
作者：
Cabello, Christopher M. [1 ]
Lamore, Sarah D. [1 ]
Bair, Warner B., III [1 ]
Bause, Alexandra S. [1 ]
Azimian, Sara [1 ]
Wondrak, Georg T. [1 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2009年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S177 / S178
页数：2
相关论文
共 50 条
  • [41] Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins
    Dong, Hongbin
    Shertzer, Howard G.
    Genter, Mary Beth
    Gonzalez, Frank J.
    Vasiliou, Vasilis
    Jefcoate, Colin
    Nebert, Daniel W.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 435 (04) : 727 - 732
  • [42] Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancer
    Lou, Shengying
    Shen, Chenjun
    Ni, Hao
    Fan, Chengcheng
    Zhu, Zhihui
    Hu, Xueping
    Zhao, Huajun
    Cui, Sunliang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 287
  • [43] Rational construction of probes rendering ratiometric response to the cancer-specific enzyme NQO1
    Fei, Qiang
    Zhou, Li
    Wang, Feiyi
    Shi, Ben
    Li, Chunbao
    Wang, Rui
    Zhao, Chunchang
    DYES AND PIGMENTS, 2017, 136 : 846 - 851
  • [44] The NQO1 bioactivatable drug, -lapachone, alters the redox state of NQO1+pancreatic cancer cells, causing perturbation in central carbon metabolism
    Silvers, Molly A.
    Deja, Stanislaw
    Singh, Naveen
    Egnatchik, Robert A.
    Sudderth, Jessica
    Luo, Xiuquan
    Beg, Muhammad S.
    Burgess, Shawn C.
    DeBerardinis, Ralph J.
    Boothman, David A.
    Merritt, Matthew E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (44) : 18203 - 18216
  • [45] High-contrast NIR fluorescent probes for selective detection of NQO1 in breast cancer
    Liu, Hongjing
    Hu, Feiyang
    Cao, Zehong
    Qu, Yi
    Wen, Hongmei
    Wang, Xinzhi
    Li, Wei
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2024, 311
  • [46] Genotype-specific progression of hereditary medullary thyroid cancer
    Machens, Andreas
    Lorenz, Kerstin
    Weber, Frank
    Dralle, Henning
    HUMAN MUTATION, 2018, 39 (06) : 860 - 869
  • [47] Systematic analysis of genotype-specific drug responses in cancer
    Kim, Nayoung
    He, Ningning
    Kim, Changsik
    Zhang, Fan
    Lu, Yiling
    Yu, Qinghua
    Stemke-Hale, Katherine
    Greshock, Joel
    Wooster, Richard
    Yoon, Sukjoon
    Mills, Gordon B.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (10) : 2456 - 2464
  • [48] Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles
    Jiao, Binbin
    Liu, Kunpeng
    Gong, Haitao
    Ding, Zhenshan
    Xu, Xin
    Ren, Jian
    Zhang, Guan
    Yu, Qingsong
    Gan, Zhihua
    JOURNAL OF CONTROLLED RELEASE, 2022, 347 : 632 - 648
  • [49] NQO1 genotype and risk of early onset lung cancer: Results from a population-based study
    Bock, Cathryn H.
    Wenzlaff, Angela S.
    Cote, Michele L.
    Land, Susan J.
    Schwartz, Ann G.
    CANCER RESEARCH, 2006, 66 (08)
  • [50] DPP9 regulates NQO1 and ROS to promote resistance to chemotherapy in liver cancer cells
    Zhou, Yunjiang
    Chen, Yaxin
    Xuan, Chenyuan
    Li, Xingyan
    Tan, Yingying
    Yang, Mengdi
    Cao, Mengran
    Chen, Chi
    Huang, Xing
    Hu, Rong
    REDOX BIOLOGY, 2024, 75
12345